Samsung Epis Holdings Co., Ltd. (KRX:0126Z0)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Biopharmaceutical Development and Commercialization	3.02T
Total	3.02T

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Europe	890.27B
outside of Europe	619.87B
Total	1.51T

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error